Diabetes Drugs Index
June 2000 through May 2001
Volume 1, Issues 1-12

How to use this index:

• Each category appears in capital letters, followed by case names or subheadings.

• Issue and page numbers are listed after each entry indicating where articles appear.

• A capital letter following a page number indicates the section of a given issue which contains a related document.

• An asterisk (*) following a page number indicates a document available via fax through Mealey’s Document Service. These documents were not published in the Report due to space limitations. For ordering information, refer to the last page of this index.

• A pound sign (#) following a page number indicates a specially priced document available only through Mealey’s Customer Service at (610) 768-7800.

• The final section of this index — Case Name and Supplemental Document List — provides an alphabetical listing of every case included in the index and document numbers for those documents that were not reprinted in the Report due to space limitations.

For example:

Iss. 12, 6/12/93, p5B
• An article appears in Issue 12, page 5 (dated June 12, 1993).
• An accompanying document is printed in Section B of that issue.

Iss. 11, 6/5/93, p8*
• An article appears in Issue 11, page 8 (dated June 5, 1993).
• A document is available through Mealey's Document Service.

Opinion: 27-950069-011
(only in Case List & Supplemental Document section)
• A document is available through Mealey's Document Service
• The document number is 27-950069-011

If you can’t find what you’re looking for, just call us at (610) 768-7800. Mealey's Customer Service Department is available to help you.

GUIDE TO ISSUE NUMBERS & PUBLICATION DATES

#1 June 2000
#2 July 2000
#3 August 2000
#4 September 2000
#5 October 2000
#6 November 2000
#7 December 2000
#8 January 2001
#9 February 2001
#10 March 2001
#11 April 2001
#12 May 2001

SECTION I: SUBJECT INDEX

ABSTENTION
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

ACTOS / PIOGLITAZONE
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
FDA, Parke-Davis say Avandia, Actos have adverse events, Iss. 2, July 2000, p18
FDA warns SmithKline that Avandia promotions are ‘false or misleading,’ Iss. 7, Nov. 2000, p14
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14
New ‘glitazone’ shows promise, Iss. 8, Jan. 2001, p14
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Plaintiffs’ attorney says drug marketing drives the science, Iss. 11, April 2001, p6
Troglitazone helped treat prostate cancer: Researchers, Iss. 2, July 2000, p17

ADVERSE SIDE EFFECTS
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Attorneys: Parke-Davis misused database to underplay Rezulin risk, Iss. 11, April 2001, p3A
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Clinical trials fail to report drug toxicity, Iss. 9, Feb. 2001, p13
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
FDA, Parke-Davis say Avandia, Actos have adverse events, Iss. 2, July 2000, p18
Glaxo’s decision to pull troglitazone is subject to dispute, Iss. 11, April 2001, p5C
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Researchers agree adverse events are not well reported, Iss. 12, May 2001, p12
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p6A
Study: patients want to be told of risks, Iss. 11, April 2001, p13

ADVERTISING
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G

ADVISORIES / RECOMMENDATIONS /
STUDIES / TESTS / MEETINGS
2 cases support concern that glitazones precipitate edema, Iss. 11, April 2001, p12
Abstract: No evidence of rosiglitazone / liver hepatoxicity problems, Iss. 2, July 2000, p18
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D
Bromocriptine improves glycemic control in Type 2 diabetes, Iss. 3, Aug. 2000, p16
Clinical trials fail to report drug toxicity, Iss. 9, Feb. 2001, p13
Diabetes strikes more than ever at a younger age, Iss. 3, Aug. 2000, p15
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
Increase seen in pediatric diabetes, Iss. 8, Jan. 2001, p13
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13
National Diabetes Center press release, Iss. 1, June 2000, p16
New ‘glitazone’ shows promise, Iss. 8, Jan. 2001, p14
New study says Rezulin / Prandin therapy effective, Iss. 2, July 2000, p17
Plaintiffs’ attorney says drug marketing drives the science, Iss. 11, April 2001, p6
Physicians in U.K. disagree over benefits of rosiglitazone, Iss. 11, April 2001, p12
Researchers agree adverse events are not well reported, Iss. 12, May 2001, p12
Researchers say Rezulin users with liver events had existing problems, Iss. 2, July 2000, p16
Rezulin-induced liver disease is treated with steroids, Iss. 7, Dec. 2000, p16
Role of companies in medical education debated in journal, Iss. 12, May 2001, p8
Studies reassert Rezulin’s efficacy, Iss. 12, May 2001, p12
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Study documents benefits and liver toxicity of troglitazone therapy, Iss. 5, Oct. 2000, p15
Study: patients want to be told of risks, Iss. 11, April 2001, p13
Study suggests prevention works for Type 2 diabetes, Iss. 12, May 2001, p11
Study will evaluate diabetes benefits of liposuction surgery, Iss. 3, Aug. 2000, p16
Survey of literature shows great promise for ‘glitazones,’ Iss. 8, Jan. 2001, p13
Troglitazone helped treat prostate cancer: Researchers, Iss. 2, July 2000, p17
Troglitazone is shown to cause death in vascular smooth cells, Iss. 7, Dec. 2000, p16
Viagra may help diabetes to keep their food down, Iss. 3, Aug. 2000, p17

ALTERNATIVE DISPUTE RESOLUTION
Judicial Council Coordination Proceeding No. 4122, Iss. 7, Dec. 2000, p8A
Rezulin cases consolidated before Justice Freeman in New York Supreme Court, Iss. 7, Nov. 2000, p12

ANTIDEPRESSANT
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*

ASSUMPTION of RISK
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
In Re: Rezulin Litigation, Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p6A

ATTORNEY-CLIENT PRIVILEGE
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p11E

ATTORNEY FEES
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 8, Jan. 2001, p4B; Iss. 10, March 2001, pC
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

AVANDIA / ROSIGLITAZONE
2 cases support concern that glitazones precipitate edema, Iss. 11, April 2001, p12
Abstract: No evidence of rosiglitazone/liver hepatoxicity problems, Iss. 2, July 2000, p18
Avandia gets partial EU clearance, Iss. 1, June 2000, p16
Avandia helps maker to strong earnings, Iss. 12, May 2001, p8
Canada approves Avandia, Iss. 1, June 2000, p16
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
FDA, Parke-Davis say Avandia, Actos have adverse events, Iss. 2, July 2000, p18
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
FDA warns SmithKline that Avandia promotions are ‘false or misleading,’ Iss. 7, Nov. 2000, p14
New ‘glitazone’ shows promise, Iss. 8, Jan. 2001, p14
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Physicians in U.K. disagree over benefits of rosiglitazone, Iss. 11, April 2001, p12
Plaintiffs’ attorney says drug marketing drives the science, Iss. 11, April 2001, p6
SmithKline announced Canadian Avandia test, Iss. 5, Oct. 2000, p17
SmithKline press release regarding Avandia, Iss. 1, June 2000, p17
Survey of literature shows great promise for ‘glitazones,’ Iss. 8, Jan. 2001, p13
Troglitazone helped treat prostate cancer: Researchers, Iss. 2, July 2000, p17

BANKRUPTCY
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p6C
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

BENEFICIAL EFFECTS
Survey of literature shows great promise for ‘glitazones,’ Iss. 8, Jan. 2001, p13

CAUSATION
Lawyer/doctor offers 3 possible causes for Rezulin liver damage, Iss. 7, Nov. 2000, p15
In Re: Rezulin Product Liability Litigation, Iss. 6, Nov. 2000, p4F,G; Iss. 9, Feb. 2001, p4B

CLASS ACTION
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D; Iss. 3, Aug. 2000, p8D
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*; Iss. 5, Oct. 2000, p11
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 8, Jan. 2001, p4B; Iss. 10, March 2001, pC
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 10, March 2001, pD7*
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6B; Iss. 8, Jan. 2001, p3D,E,F; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p6A; Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p6
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Task force to study class counsel selection, Iss. 10, March 2001, p16
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9

CLASS CERTIFICATION
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p6; Iss. 12, May 2001, p6
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13

CLINICAL TRIALS / STUDIES
Abstract: No evidence of rosiglitazone/liver hepatoxicity problems, Iss. 2, July 2000, p18
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Clinical trials fail to report drug toxicity, Iss. 9, Feb. 2001, p13
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
FDA will allow Rezulin medical officer to give a deposition, Iss. 10, March 2001, p9
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6C
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
SmithKline press release regarding Avandia, Iss. 1, June 2000, p17

COMMON FUND FEE
In Re: Rezulin Products Liability Litigation, Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O

COMMON INTEREST DOCTRINE
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 12, May 2001, p6*

COMPENSATION
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

CONFLICT of INTEREST
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
In Re: Rezulin Product Liability Litigation, Iss. 5, Oct. 2000, p46B

CONSPIRACY
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p11E

CONSTITUTIONAL ISSUES
First Amendment
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C

Free Speech
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C

CONSULTANTS
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*

CONSUMER FRAUD
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Judicial Council Coordination Proceeding No. 4122, Iss. 5, Oct. 2000, p11

CONSUMER PROTECTION
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13

CONTRIBUTORY / COMPARATIVE NEGLIGENCE
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 5, Oct. 2000, p12C,D,E,I

COORDINATION / CONSOLIDATION
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Re: Designation of Rezulin Litigation as a Mass Tort, Iss. 1, June 2000, p8E
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*; Iss. 4, Sept. 2000, p4A; Iss. 5, Oct. 2000, p11; Iss. 7, Nov. 2000, p12; Iss. 7, Dec. 2000, p8A
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p11E; Iss. 9, Feb. 2001, p12F
Rezulin cases consolidated before Justice Freeman in New York Supreme Court, Iss. 7, Nov. 2000, p12
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 8, Jan. 2001, p4A; Iss. 8, Jan. 2001, p6C; Iss. 10, March 2001, p7*; Iss. 10, March 2001, p8F; Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p6C; Iss. 7, Dec. 2000, p6B; Iss. 7, Dec. 2000, p8; Iss. 8, Jan. 2001, p3D,E,F; Iss. 9, Feb. 2001, p6A; Iss. 10, March 2001, p6
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., Iss. 3, Aug. 2000, p7E
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9

CORPORATE COMMUNICATIONS
In Re: Rezulin Products Liability Litigation, Iss. 12, May 2001, p4C

CORPORATE NEWS
Rezulin withdrawal cost Pfizer $103 million, Iss. 2, July 2000, p19
SmithKline announced Canadian Avandia test, Iss. 5, Oct. 2000, p17

Litigation Status
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9
Warner-Lambert says it will try to settle Rezulin death cases, Iss. 5, Oct. 2000, p9

Merger
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

Press Releases
National Diabetes Center press release, Iss. 1, June 2000, p16
SmithKline press release regarding Avandia, Iss. 1, June 2000, p17

Quarterly Reports
Avandia helps maker to strong earnings, Iss. 12, May 2001, p8
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
Pfizer third-quarter report itemizes company losses stemming from Rezulin, Iss. 7, Nov. 2000, p16
Rezulin’s successors post sales gains, Iss. 7, Nov. 2000, p16
Rezulin withdrawal cuts Pfizer earnings, Iss. 9, Feb. 2001, p14

DAMAGES
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I

Compensatory Damages
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

Exemplary Damages
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*

Noneconomic Damages
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

Punitive Damages
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

Treble Damages
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A

DAUBERT ISSUES
In Re: Rezulin Product Liability Litigation, Iss. 6, Nov. 2000, p4F,G

DECEPTIVE TRADE PRACTICES
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*

DECEIT
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC

DEFECTIVE PRODUCTS
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

DELIBERATIVE PROCESS PRIVILEGE
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*

DISCOVERY
Case Management Order
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*; Iss. 7, Dec. 2000, p8A
In Re: New York Rezulin Product Liability, Iss. 7, Dec. 2000, p10G; Iss. 9, Feb. 2001, p8C*
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p6C
In Re: Rezulin Products Liability Litigation, Iss. 2, July 2000, p13; Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Iss. 5, Oct. 2000, p4A,B,G; Iss. 11, April 2001, p8F

Databases
Attorneys: Parke-Davis misused database to underplay Rezulin risk, Iss. 11, April 2001, p3A
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p5F

Depositions
Glaxo’s decision to pull troglitazone is subject to dispute, Iss. 11, April 2001, p5C
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p4E; Iss. 12, May 2001, p4D

Document Production
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*
Griggs v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p6D,E,F,G*
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I

Duplicative Discovery
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A

Ex Parte Motions
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*

Failure to Produce Documents
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G

In Camera Review
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*

In Limine Motions
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6B

Interrogatories
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 7, Nov. 2000, p11*
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 10, March 2001, pD7*; Iss. 10, March 2001, p8F
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6C

Medical Records
Iss. 9, Feb. 2001, p8C*

Order to Show Cause
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., Iss. 3, Aug. 2000, p7E

Patient Profiles
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H

Privilege Log
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*

Preservation of Documents
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p6C

Protective Orders / Confidentiality Orders
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 4, Sept. 2000, p6D,E,F,G*
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
Judicial Council Coordination Proceeding No. 4122, Iss. 7, Dec. 2000, p8A
In Re: New York Rezulin Product Liability, Iss. 7, Dec. 2000, p10G; Iss. 9, Feb. 2001, p12F
In Re: Rezulin Products Liability Litigation, Iss. 2, July 2000, p8; Iss. 2, July 2000, p13; Iss. 6, Nov. 2000, p4D; Iss. 7, Dec. 2000, p6C

Subpoenas
In Re: Rezulin Products Liability Litigation, Iss. 11, April 2001, p7D

DISEASES / CONDITIONS
Atherosclerosis
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14

Cardiac Complications / Damage
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Plaintiffs’ attorney says drug marketing drives the science, Iss. 11, April 2001, p6
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 9, Feb. 2001, p6A

Cirrhosis
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Lawyer/doctor offers 3 possible causes for Rezulin liver damage, Iss. 7, Nov. 2000, p15

Congestive Heart Failure
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p4B

Heart Valve Damage
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*

Hepatitis
Lawyer / doctor offers 3 possible causes for Rezulin liver damage, Iss. 7, Nov. 2000, p15

Liver Cancer
Lawyer / doctor offers 3 possible causes for Rezulin liver damage, Iss. 7, Nov. 2000, p15

Liver Failure / Damage
Attorneys: Parke-Davis misused database to underplay Rezulin risk, Iss. 11, April 2001, p3A
Avandia helps maker to strong earnings, Iss. 12, May 2001, p8
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Canada approves Avandia, Iss. 1, June 2000, p16
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Lawyer / doctor offers 3 possible causes for Rezulin liver damage, Iss. 7, Nov. 2000, p15
Lawyer / doctor opines on ‘good’ Rezulin clients, Iss. 2, July 2000, p12
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 6, Nov. 2000, p4F,G; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p6A
Rezulin withdrawal cuts Pfizer earnings, Iss. 9, Feb. 2001, p14
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Study documents benefits and liver toxicity of troglitazone therapy, Iss. 5, Oct. 2000, p15

DISGORGEMENT of PROFITS
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

DRUG APPROVAL
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7

DUTY to WARN
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E

EMERGENCY NOTICE
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14

FACT SHEET
In Re: New York Rezulin Product Liability, Iss. 7, Dec. 2000, p10G; Iss. 9, Feb. 2001, p8C*

FAILURE to WARN
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F; Iss. 10, March 2001, p3A
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

FALSE and MISLEADING
STATEMENTS / ADVERTISING
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
FDA warns SmithKline that Avandia promotions are ‘false or misleading,’ Iss. 7, Nov. 2000, p14

FAST TRACK REVIEW
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14

FOOD and DRUG ADMINISTRATION
Abstract: No evidence of rosiglitazone / liver hepatoxicity problems, Iss. 2, July 2000, p18
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Canada approves Avandia, Iss. 1, June 2000, p16
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*; Iss. 12, May 2001, p6*
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
FDA blames doctors for failure to read drug warnings, Iss. 8, Jan. 2001, p10
FDA issues rule on child testing, Iss. 12, May 2001, p15
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
FDA, Parke-Davis say Avandia, Actos have adverse events, Iss. 2, July 2000, p18
FDA proposes new regulations to reduce errors, Iss. 10, March 2001, p16
FDA warns Aventis on ‘misleading’ promotions, Iss. 11, April 2001, p11
FDA warns SmithKline that Avandia promotions are ‘false or misleading,’ Iss. 7, Nov. 2000, p14
FDA will allow Rezulin medical officer to give a deposition, Iss. 10, March 2001, p9
Griggs v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p6D,E,F,G*; Iss. 7, Dec. 2000, p8D
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
National Diabetes Center press release, Iss. 1, June 2000, p16
Public Citizen takes FDA to task over public information, Iss. 12, May 2001, p14
Researchers say Rezulin users with liver events had existing problems, Iss. 2, July 2000, p16
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A; Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p5F; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p6A; Iss. 11, April 2001, p7D; Iss. 12, May 2001, p4C
Rezulin transcripts posted, Iss. 1, June 2000, p15
Rezulin withdrawal cuts Pfizer earnings, Iss. 9, Feb. 2001, p14
SmithKline announced Canadian Avandia test, Iss. 5, Oct. 2000, p17
SmithKline press release regarding Avandia, Iss. 1, June 2000, p17
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Warner-Lambert says it will try to settle Rezulin death cases, Iss. 5, Oct. 2000, p9

FOREIGN ACTIONS / NEWS
Avandia gets partial EU clearance, Iss. 1, June 2000, p16
Canada approves Avandia, Iss. 1, June 2000, p16
Japanese doctors theorize that alcohol use enhance troglitazone’s toxicity, Iss. 5, Oct. 2000, p16
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14
Physicians in U.K. disagree over benefits of rosiglitazone, Iss. 11, April 2001, p12
SmithKline announced Canadian Avandia test, Iss. 5, Oct. 2000, p17
Troglitazone is shown to cause death in vascular smooth cells, Iss. 7, Dec. 2000, p16

FRAUD
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 10, March 2001, p3A

FRAUD by OMISSION
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

FRAUD on the FDA
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G

FRAUDULUENT CONCEALMENT / SUPPRESSION
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

HEALTH BENEFIT PROVIDER
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13
In Re: Rezulin Product Liability Litigation, Iss. 5, Oct. 2000, p46B; Iss. 7, Dec. 2000, p5F; Iss. 11, April 2001, p8F

IMMUNITY
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A

INFORMED CONSENT
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
In Re: Rezulin Litigation, Iss. 12, May 2001, p3A,B

INJURY COMPENSATION
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

INSURANCE ISSUES
Aggregate Limit
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I

Bad Faith
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC

Breach of Express Warranty
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

Breach of Implied Warranty
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L; Iss. 8, Jan. 2001, p3D,E,F
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

Breach of Implied Warranty of Merchantability
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

Fiduciary Duty
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC

Investigational New Drug / New Drug Application
(IND/NDA)
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14

JOINDER / FRAUDULENT JOINDER
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E; Iss. 8, Jan. 2001, p3D,E,F; Iss. 10, March 2001, p3A; Iss. 12, May 2001, p5D
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

JOINT REPRESENTATION AGREEMENT
In Re: Rezulin Products Liability Litigation, Iss. 2, July 2000, p8

JURISDICTION
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p12F
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 8, Jan. 2001, p4B; Iss. 10, March 2001, pC
In Re: Rezulin Litigation, Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p6C; Iss. 8, Jan. 2001, p3D,E,F; Iss. 10, March 2001, p3A; Iss. 12, May 2001, p5D
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

LEARNED INTERMEDIARY DOCTRINE
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 7, Nov. 2000, p11*
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
In Re: Rezulin Litigation, Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E; Iss. 9, Feb. 2001, p6A; Iss. 10, March 2001, p3A
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

LEGISLATION, FEDERAL
Freedom of Information Act
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 4, Sept. 2000, p6D,E,F,G*

Food, Drug and Cosmetic Act
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*

LEGISLATION, STATE
California
California Business and Professions Code
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*

Connecticut
Connecticut Unfair Trade Practices Act
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 10, March 2001, pC

Mississippi
Mississippi Product Liability Act
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

Missouri
Missouri Product Liability Act
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*

New Jersey
New Jersey Consumer Fraud Act
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

New Jersey Products Liability Act
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F

Texas
Texas Deceptive Trade Practices Act
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*

LOSS of CONSORTIUM
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G

MANAGED CARE
FDA blames doctors for failure to read drug warnings, Iss. 8, Jan. 2001, p10

MARKETING / PROMOTION
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 7, Nov. 2000, p11*
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
FDA warns SmithKline that Avandia promotions are ‘false or misleading,’ Iss. 7, Nov. 2000, p14
Glaxo’s decision to pull troglitazone is subject to dispute, Iss. 11, April 2001, p5C
Internal FDA study of Rezulin’s approval finds problems, Iss. 7, Dec. 2000, p13
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
Physicians in U.K. disagree over benefits of rosiglitazone, Iss. 11, April 2001, p12
Plaintiffs’ attorney says drug marketing drives the science, Iss. 11, April 2001, p6
Researchers say Rezulin users with liver events had existing problems, Iss. 2, July 2000, p16
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 11, April 2001, p7D
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
Study documents benefits and liver toxicity of troglitazone therapy, Iss. 5, Oct. 2000, p15
Warner-Lambert names Kaye Scholer national coordinating counsel, Iss. 2, July 2000, p13
Warner-Lambert says it will try to settle Rezulin death cases, Iss. 5, Oct. 2000, p9

MASS TORT
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 12, May 2001, p6
Judicial Council Coordination Proceedings No. 4122, Iss. 7, Nov. 2000, p12
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p6C
In Re: Rezulin Products Liability Litigation, Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O

MEDICAL MALPRACTICE
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 5, Oct. 2000, p12C,D,E,I
Rezulin cases consolidated before Justice Freeman in New York Supreme Court, Iss. 7, Nov. 2000, p12

MEDICAL MISTAKES
FDA proposes new regulations to reduce errors, Iss. 10, March 2001, p16

MEDICAL MONITORING
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D; Iss. 3, Aug. 2000, p8D
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 6, Nov. 2000, p4F,G; Iss. 8, Jan. 2001, p3D,E,F; Iss. 9, Feb. 2001, p4B
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9

MEDICAL SCREENING
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D

MISREPRESENTATION
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C

MULTIDISTRICT LITIGATION (MDL)
90 federal lawsuits transferred to MDL, Iss. 2, July 2000, p13
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*; Iss. 12, May 2001, p6*
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 4, Sept. 2000, p6D,E,F,G*
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
In Re: Rezulin Litigation, Iss. 10, March 2001, pD7*
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 2, July 2000, p8; Iss. 2, July 2000, p13; Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Iss. 4, Sept. 2000, p11; Iss. 5, Oct. 2000, p4A; Iss. 5, Oct. 2000, p46B; Iss. 6, Nov. 2000, p4D; Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p6B; Iss. 7, Dec. 2000, p8; Iss. 8, Jan. 2001, p3D,E,F; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p3A; Iss. 10, March 2001, p4E; Iss. 11, April 2001, p7D; Iss. 11, April 2001, p8F; Iss. 12, May 2001, p4D; Iss. 12, May 2001, p5D
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., Iss. 3, Aug. 2000, p7E
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9

NEGLIGENCE / NEGLIGENCE PER SE
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A; Iss. 12, May 2001, p3A,B
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

NEGLIGENT MISREPRESENTATION
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

OFF-LABEL USE
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*

OPT-OUT
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

PACKAGE INSERTS
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I

PATENT INFRINGEMENT
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 12, May 2001, p6*

PERSONAL INJURY
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6B

PHARMACY / PHARMACIST DEFENDANTS
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E; Iss. 10, March 2001, p3A
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

PHYSICIAN LIABILITY
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

PIOGLITAZONE
[See ACTOS / PIOGLITAZONE]

PREEMPTION
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p6A
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G

PRODUCT LIABILITY / STRICT LIABILITY
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 8, Jan. 2001, p3D,E,F
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

PROPULSID
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E

PROXIMATE CAUSE
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

PUBLIC INTEREST
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C

RECUSAL
Judicial Council Coordination Proceeding No. 4122, Iss. 7, Dec. 2000, p8A
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p8

REGULATORY AFFAIRS
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
In Re: Rezulin Products Liability Litigation, Iss. 11, April 2001, p7D; Iss. 12, May 2001, p4D

REIMBURSEMENT
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M

REMAND
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 8, Jan. 2001, p4B; Iss. 10, March 2001, pC
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 2, July 2000, p8; Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p6B; Iss. 10, March 2001, p3A; Iss. 11, April 2001, p11E
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

REMOVAL to FEDERAL COURT
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4A,B,C
Judicial Council Coordination Proceeding No. 4122, Iss. 5, Oct. 2000, p11
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p6C
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

RESTITUTION
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*

REZULIN / TROGLITAZONE
90 federal lawsuits transferred to MDL, Iss. 2, July 2000, p13
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L; Iss. 7, Nov. 2000, p11*
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Attorneys: Parke-Davis misused database to underplay Rezulin risk, Iss. 11, April 2001, p3A
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Canada approves Avandia, Iss. 1, June 2000, p16
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Delaney, John and Michael E. O’Keefe, et al. v. Warner-Lambert Company and Parke, Davis & Co., Iss. 2, July 2000, p5C
Re: Designation of Rezulin Litigation as a Mass Tort, Iss. 1, June 2000, p8E
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14
FDA will allow Rezulin medical officer to give a deposition, Iss. 10, March 2001, p9
Glaxo’s decision to pull troglitazone is subject to dispute, Iss. 11, April 2001, p5C
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 5, Oct. 2000, p12C,D,E,I
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p13M
Japan’s health ministry orders maker of Actos to issue a warning, Iss. 5, Oct. 2000, p14
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*; Iss. 4, Sept. 2000, p4A; Iss. 5, Oct. 2000, p11; Iss. 7, Nov. 2000, p12
Lawyer / doctor opines on ‘good’ Rezulin clients, Iss. 2, July 2000, p12
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
New ‘glitazone’ shows promise, Iss. 8, Jan. 2001, p14
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p11E; Iss. 9, Feb. 2001, p12F
Pfizer Inc. says Rezulin suits have little impact, Iss. 12, May 2001, p7
Pfizer third-quarter report itemizes company losses stemming from Rezulin, Iss. 7, Nov. 2000, p16
Rezulin cases consolidated before Justice Freeman in New York Supreme Court, Iss. 7, Nov. 2000, p12
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 10, March 2001, pD7*; Iss. 10, March 2001, p8F; Iss. 10, March 2001, p8F; Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 2, July 2000, p8; Iss. 4, Sept. 2000, p11; Iss. 5, Oct. 2000, p4A; Iss. 5, Oct. 2000, p46B; Iss. 6, Nov. 2000, p4D; Iss. 7, Dec. 2000, p5F; Iss. 7, Dec. 2000, p6C; Iss. 7, Dec. 2000, p6B; Iss. 7, Dec. 2000, p8; Iss. 8, Jan. 2001, p3D,E,F; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p6A; Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p3A; Iss. 10, March 2001, p4E; Iss. 11, April 2001, p7D; Iss. 11, April 2001, p8F; Iss. 12, May 2001, p4C; Iss. 12, May 2001, p5D
Rezulin’s successors post sales gains, Iss. 7, Nov. 2000, p16
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G
Studies reassert Rezulin’s efficacy, Iss. 12, May 2001, p12
Study: doctors fail to follow up on liver abnormalities, Iss. 9, Feb. 2001, p13
Survey of literature shows great promise for ‘glitazones,’ Iss. 8, Jan. 2001, p13
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., Iss. 3, Aug. 2000, p7E

RISK / BENEFIT
Clinical trials fail to report drug toxicity, Iss. 9, Feb. 2001, p13
FDA, Parke-Davis say Avandia, Actos have adverse events, Iss. 2, July 2000, p18
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Researchers say Rezulin users with liver events had existing problems, Iss. 2, July 2000, p16

ROSIGLITAZONE
[See AVANDIA/ROSIGLITAZONE]

SAFER DRUGS / ALTERNATIVES
FDA officer says Rezulin withdrawn because newer drugs proved safer, Iss. 1, June 2000, p7
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
SmithKline announced Canadian Avandia test, Iss. 5, Oct. 2000, p17

SANCTIONS
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
Judicial Council Coordinating Proceeding No. 4122, Iss. 2, July 2000, p6A,B,D,E,F*

SETTLEMENT
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D
In Re: Rezulin Products Liability Litigation, Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Iss. 6, Nov. 2000, p4F,G
Warner-Lambert says it will try to settle Rezulin death cases, Iss. 5, Oct. 2000, p9

SOCIAL SECURITY BENEFITS
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p8C*

SPECIAL MASTER
Re: Designation of Rezulin Litigation as a Mass Tort, Iss. 1, June 2000, p8E
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 10, March 2001, p8F

STATE-OF-THE-ART DEFENSE
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*

STATUTE of LIMITATIONS
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D

STAY
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
Judicial Council Coordination Proceeding No. 4122, Iss. 4, Sept. 2000, p4A

STRICT LIABILITY
[See PRODUCTS LIABILITY/STRICT LIABILITY]

SUBROGATION
In Re: Rezulin Product Liability Litigation, Iss. 5, Oct. 2000, p46B

SUMMARY JUDGMENT
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 7, Nov. 2000, p11*
In Re: Rezulin Litigation, Iss. 10, March 2001, pD7*
In Re: Rezulin Product Liability Litigation, Iss. 6, Nov. 2000, p4F,G

THIRD PARTY / THIRD PARTY LIABILITY
Aiello, Pasquale and Yee Feeshang v. Parke Davis, Iss. 3, Aug. 2000, p8D
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*

TRADE SECRETS
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p12F
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p6C

TRANSFER of CASES
90 federal lawsuits transferred to MDL, Iss. 2, July 2000, p13
Judicial Council Coordination Proceeding No. 4122, Iss. 4, Sept. 2000, p4A
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p6A; Iss. 10, March 2001, p3A
Warner-Lambert faces 568 state and federal lawsuits over Rezulin, Iss. 5, Oct. 2000, p9

TROGLITAZONE
[See REZULIN/TROGLITAZONE]

UNFAIR COMPETITION
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G

UNFAIR TRADE PRACTICES
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*

UNJUST ENRICHMENT
In Re: Rezulin Products Liability Litigation, Iss. 8, Jan. 2001, p3D,E,F
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*

VERDICT
In Re: Rezulin Products Liability Litigation, Iss. 7, Dec. 2000, p4E

WANTON and RECKLESS DISREGARD
Rose, Theodore et al. v. Parke-Davis, et al., Iss. 2, July 2000, p4G

WARNINGS / WARNING LABELS
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 7, Nov. 2000, p11*
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6C*
Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Diabetes rates up 6 percent in 1999, Iss. 9, Feb. 2001, p14
Executives admit advertisements were not ‘the whole truth,’ Iss. 11, April 2001, p3B
Griggs, Shirley et al v. Warner-Lambert Company, Iss. 5, Oct. 2000, p12C,D,E,I
FDA blames doctors for failure to read drug warnings, Iss. 8, Jan. 2001, p10
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
Japanese doctors theorize that alcohol use enhance troglitazone’s toxicity, Iss. 5, Oct. 2000, p16
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
Lumpkin says Rezulin wasn’t fast-tracked, Iss. 2, July 2000, p14
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
National Diabetes Center press release, Iss. 1, June 2000, p16
In Re: Rezulin Litigation, Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, Iss. 9, Feb. 2001, p4B
Rivera, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*

WHISTLEBLOWER
FDA official told to keep quiet about Avandia test problem, Iss. 3, Aug. 2000, p14

WORKERS’ COMPENSATION
In Re: New York Rezulin Product Liability, Iss. 9, Feb. 2001, p8C*

WORK PRODUCT
In Re: Rezulin Product Liability Litigation, Iss. 6, Nov. 2000, p4D

WRONGFUL DEATH
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 4, Sept. 2000, p11J,K,L; Iss. 7, Nov. 2000, p11*
Holveck, Victor B. Jr. et al. v. Warner-Lambert Co., Iss. 5, Oct. 2000, p10*
McBride, Lillian v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p11J,K,L
In Re: Rezulin Litigation, Iss. 8, Jan. 2001, p4A
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 4, Sept. 2000, p11J,K,L

ZOLOFT
Motus, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*

SECTION II: JURISDICTION INDEX

A. FEDERAL COURTS
U.S. Supreme Court
Buckman Co. v. Plaintiffs’ Legal Committee, Iss. 10, March 2001, p10*

U.S. DISTRICT COURTS
California
Jackson, Mamie et al. v. Warner-Lambert, et al., Iss. 5, Sept. 2000, p13M
Judicial Counsel Coordinating Proceeding, Iss. 2, July 2000, p6A,B,D,E,F; Iss. 4, Sept. 2000, p4A; Iss. 5, Oct. 2000, p11;Iss. 6, Nov. 2000, p12;Iss. 7, Dec. 2000, p8A
Motis, Flora v. Pfizer Inc., Iss. 8, Jan. 2001, p7*
In Re: Rezulin Litigation, Iss. 10, March 2001, p7D*

Iowa
Houk, Jerry Dean et al. v. Warner-Lambert Co., Iss. 1, June 2000, p9*

Louisiana
Futrell, Sonia v. Warner-Lambert, et al., Iss. 5, Sept. 2000, p13*
Pendleton, Mary et al. v. Parke-Davis, et al., Iss. 8, Jan. 2001, p4B; Iss. 10, March 2001, p6C

Massachusetts
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, Iss. 1, June 2000, p8D; Iss. 3, Aug. 2000, p8D
Ashe, David C. et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

Michigan
Kent, Kimberly et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

New Jersey
Appel, Marilyn et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*
Fessaguet v. Warner-Lambert, Iss. 1, June 2000, p9*

New York
In Re: Rezulin Products Liability Litigation, Iss. 2, July 2000, p8; Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; I, Iss. 4, Sept. 4, p11; Iss. 5, Oct. 2000, p4A,G; Iss. 5, Oct. 2000, p6B; Iss. 6, Nov. 2000, p4F,G; Iss. 6, Nov. 2000, p4D,E; Iss. 7, Dec. 2000, p4E; Iss. 7, Dec. 2000, p5F; Iss. 7, Dec. 2000, p6C; Iss. 7, Dec. 2000, p6B; Iss. 7, Dec. 2000, p8; Iss. 8, Jan. 2001, p3E*; Iss. 9, Feb. 2001, p4B; Iss. 9, Feb. 2001, p6A; Iss. 9, Feb. 2001, p7D; Iss. 10, March 2001, p3A; Iss. 10, March 2001, p4E; Iss. 10, March 2001, p6; Iss. 11, April 2001, p7D; Iss. 11, April 2001, p8F; Iss. 11, April 2001, p11E; Iss. 12, May 2001, p4C; Iss. 12, April 2001, p4F; Iss. 12, May 2001, p5D; Iss. 12, May 2001, p6E

Ohio
Velerius, Wanda v. Warner-Lambert, Iss. 1, June 2000, p9*
Weisman, Alan v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

Pennsylvania
Catanzaro, Joel et al. v. Warner-Lambert, Iss. 1, June 2000, p9*
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, Iss. 7, Dec. 2000, p14*; Iss. 12, May 2001, p6*
Pinsker, Sanford et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

Texas
Rivers, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., Iss. 7, Dec. 2000, p15*

B. STATE COURTS
California
California Disability Rights v. Warner-Lambert, et al., Iss. 1, June 2000, p3G
Copeland, Euretta v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p4B,C
Delaney, John and Michael E. O’Keefe et al. v. Warner-Lambert Company and Parke-Davis & Co., Iss. 2, July 2000, p5C
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., Iss. 1, July 2000, p6F*; Iss. 3, Aug. 2000, p7E

Delaware
Holveck, Victor R. Jr. et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*; Iss. 5, Oct. 2000, p10*

District of Columbia
Seay, Rosetta et al. v. Warner-Lambert Co., Iss. 1, June 2000, p9*

Maryland
Shaw, Andrea et al. v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

Massachusetts
Rose, Theodore et al. v. Parke-Davis et al., Iss. 2, July 2000, p4G
Scherer, Charles et al. v. Parke-Davis, et al., Iss. 1, June 2000, p9*

Mississippi
Teague, Robert et al. v. Parke-Davis, et al., Iss. 5, Oct. 2000, p13F,H

Missouri
Griggs v. Warner-Lambert, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*; Iss. 4, Sept. 2000, p6D,E,F,G*; Iss. 5, Oct. 2000, p12C,D,E,I; Iss. 7, Dec. 2000, p8D

New Jersey
Re: Designation of Rezulin Litigation as a Mass Tort, Iss. 1, June 2000, p8E
King, Althea C. v. Warner-Lambert, et al., Iss. 4, Sept. 2000, p8H,I
In Re: Rezulin Litigation, Iss. 7, Dec. 2000, p10H; Iss. 8, Jan. 2001, p4A; Iss. 8, Jan. 2001, p6C; Iss. 10, March 2001, p8F; Iss. 12, May 2001, p3A,B
Rowan v. Warner-Lambert, Iss. 1, June 2000, p9*

New York
Dallow v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
Leon v. Pfizer, et al., Iss. 3, Aug. 2000, p15*
In Re: New York Rezulin Product Liability, Iss. 7, Dec. 2000, p10G; Iss. 9, Feb. 2001, p8C*; Iss. 9, Feb. 2001, p11E;Iss. 9, Feb. 2001, p12F

Pennsylvania
Hopkins, Charlie Fae et al. v. Pfizer Inc., et al., Iss. 5, Sept. 2000, p13*
Tucker, Stephen I. V. Warner-Lambert, et al., Iss. 1, June 2000, p9*

Texas
Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., Iss. 5, Sept. 2000, p12J; Iss. 6, Nov. 2000, p11*
Baginskie, Brenda et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p6B,C*
Gordon, Connie et al. v. Warner-Lambert, Iss. 6, Nov. 2000, p8A
McBride, Lillian v. Warner-Lambert, et al., Iss. 5, Sept. 2000, p12J
Richardson, Brenda J. v. Warner-Lambert Co., et al., Iss. 5, Sept. 2000, p12J

West Virginia
McCaffery, Sandra v. Warner-Lambert Co., et al., Iss. 1, June 2000, p9*

C. JUDICIAL PANEL on
MULTIDISTRICT LITIGATION
In Re: Rezulin Products Liability Litigation, Iss. 1, June 2000, p3A; Iss. 2, July 2000, p13; Iss. 2, July 2000, p13;Iss. 2, July 2000, p13

SECTION III: CASE NAME and SUPPLEMENTAL DOCUMENT LIST

Abbott, Kenneth W. et al. v. Warner-Lambert Company, et al., No. 00-08-12,020-CV, Texas Dist., Robertson Co., Houston firm files 2 wrongful death suits in state courts, Iss. 5, Sept. 2000, p12J; Interrogatories filed in ‘wrongful death,’ Iss. 6, Nov. 2000, p11*
Interrogatories: Doc# 19-001108-005
Aiello, Pasquale and Yee Feeshang v. Parke-Davis, No. 00CV1097REK, D. Mass., Mass. lawsuit defines subclasses, Iss. 1, June 2000, p8D; Warner-Lambert admits paying government consultants on Rezulin, Iss. 3, Aug. 2000, p8D
Appel, Marilyn et al. v. Warner-Lambert Co., et al., No. 00-1498, D. N.J., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p9*
Complaint: Doc# 28-000406-105
Ashe, David C. et al. v. Warner-Lambert Co., et al., No. 00-10753, D. Mass., Boston Div., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-012
Baginskie, Brenda et al. v. Warner-Lambert, No. 9950681, Texas Dist., Harris Co., Warner-Lambert will product Rezulin study FDA allegedly buried, Iss. 6, Nov. 2000, p6B,C*
Production Request: Doc# 19-001108-004
Buckman Co. v. Plaintiffs’ Legal Committee, No. 98-1768, U.S. Sup., Supreme Court rejects fraud on the FDA in pedicle screw case, Iss. 10, March 2001, p10*
Opinion: Doc# 41-010222-106
California Disability Rights v. Warner-Lambert, et al., No. Sc055268, Calif. Sup., Los Angeles judge tentatively sanctions Warner-Lambert during discovery hearing, Iss. 1, June 2000, p3G
Catanzaro, Joel et al. v. Warner-Lambert, No. 00-504, W.D. Pa., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-104
Copeland, Euretta v. Warner-Lambert, et al., No. CV 241408, Calif. Super., Kern Co., Original California consolidation case back in state court, Iss. 4, Sept. 2000, p4B,C
Dallow v. Pfizer, et al., No. 116346-00, N.Y. Sup., N.Y. Co., Napoli Kaiser firm brings 2 new suits in New York state courts, Iss. 3, Aug. 2000, p15*
Complaint: Doc# 19-000830-001
Delaney, John and Michael E. O’Keefe et al. v. Warner-Lambert Company and Parke-Davis & Co., No. BC 227414, Calif. Super., Los Angeles Co., Central Dist., Warner-Lambert contends class action infringes its right of free speech, Iss. 2, July 2000, p5C
Re: Designation of Rezulin Litigation as a Mass Tort, N.J. Sup., Rezulin cases consolidated in New Jersey, Iss. 1, June 2000, p8E
In Re: Diet Drugs (Phentermine/Fenfluramine/Dexfenfluramine) Product Liability Litigation, MDL 1203, E.D. Pa., FDA must produce some privileged documents to PMC, Iss. 7, Dec. 2000, p14*
Order: Doc# 35-001109-104;
Diet drug judge rejects privilege claim for 9, 500 AHP documents, Iss. 12, May 2001, p6*
Memorandum Order: Doc# 35-010517-101Z
Fessaguet v. Warner-Lambert, No. MRS-L-937-00, D. N.J., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p9*
Futrell, Sonia v. Warner-Lambert, et al., No. OC-325-C-MI, M.D. La., Warner-Lambert target of 3 class action suits, Iss. 5, Sept. 2000, p13*
Complaint: Doc# 19-000928-016
Gordon, Connie et al. v. Warner-Lambert, No. 32,315-99-8, Texas Dist., Angelina Co., Texas plaintiff lawyer says Warner-Lambert is stalling on discovery, Iss. 6, Nov. 2000, p8A
Griggs v. Warner-Lambert, No. CV1003957CC, Mo. Cir. Clay Co., Lawyers battle over specifics of Rezulin discovery, Iss. 3, Aug. 2000, p4F,G,H,I,J,K*
Complaint: Doc# 19-000830-019
Warner-Lambert Proposed Protective Order:
Doc# 19-000830-115
Plaintiffs’ Application: Doc# 19-000830-113
Plaintiffs’ Emergency Motion: Doc# 19-000830-111
Warner-Lambert Motion for Stay:
Doc# 19-000830-114
Answers: Doc# 19-000830-020;
Discovery begins in an early case in Missouri, Iss. 4, Sept. 2000, p6D,E,F,G*
Transcript: Doc# 19-000928-008;
Missouri case remanded; joinder of physician ruled a valid cause of action, Iss. 5, Oct. 2000, p12C,D,E,I; Missouri plaintiff seeks testimony of Jamaica health ministry employee, Iss. 7, Dec. 2000, p8D
Holveck, Victor R. Jr. et al. v. Warner-Lambert Co., et al., No. 00C-03-240WTQ, Del. Super., New Castle Co., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-010
Warner-Lambert argues discovery be limited to labeling issues, Iss. 5, Oct. 2000, p10*
Responses: Doc# 19-001018-008
Hopkins, Charlie Fae et al. v. Pfizer Inc., et al., Pa. Comm. Pls., Philadelphia Co., Warner-Lambert target of 3 class action suits, Iss. 5, Sept. 2000, p13*
Complaint: Doc# 19-000928-017
Houk, Jerry Dean et al. v. Warner-Lambert Co., et al., No. 00-70205, S.D. Iowa, Central Div., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-011
Jackson, Mamie et al. v. Warner-Lambert, et al., No. 00-03845, C.D. Calif., Warner-Lambert target of 3 class action suits, Iss. 5, Sept. 2000, p13M
Judicial Counsel Coordinating Proceeding No. 4122, Calif. Super., Los Angeles Co., California state judge stays state cases pending consolidation Iss. 2, July 2000, p6A,B,D,E,F; Calif. consolidation will take place in central civil west, Iss. 4, Sept. 2000, p4A; Judge steps down after challenge from plaintiff’s attorneys, Iss. 5, Oct. 2000, p11; Judge will coordinate Rezulin litigation in California, Iss. 6, Nov. 2000, p12; Judge’s order sets the context for Calif. coordination, Iss. 7, Dec. 2000, p8A
Kent, Kimberly et al. v. Warner-Lambert Co., et al., E.D. Mich., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-103
King, Althea C. v. Warner-Lambert, et al., No. 1-3863-00, N.J. Super., Middlesex Co., Interrogatories filed in New Jersey case alleging injuries, Iss. 4, Sept. 2000, p8H,I
Leon v. Pfizer, et al., No. 25825-00, N.Y. Sup., Kings Co., Napoli Kaiser firm brings 2 new suits in New York state courts, Iss. 3, Aug. 2000, p15*
Complaint: Doc# 19-000830-002
McBride, Lillian v. Warner-Lambert, et al., No. 2000-42692, Texas Dist., Harris Co., Houston firm files 2 wrongful death suits in state courts, Iss. 5, Sept. 2000, p12J
McCaffery, Sandra v. Warner-Lambert Co., et al., W.Va. Cir., Mason Co., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-106
Motis, Flora v. Pfizer Inc., No. 00-00298, C.D. Calif., Additional drug warnings not preempted, may help, judge rules in Zoloft case, Iss. 8, Jan. 2001, p7*
Order: Doc# 28-001221-105
In Re: New York Rezulin Product Liability, No. 752000-00, N.Y. Sup., N.Y. Co., Lawyers circulate a draft CMO in N.Y. state cases, Iss. 7, Dec. 2000, p10G; Fact sheet approved by New York justice, Iss. 9, Feb. 2001, p8C*
Plaintiff’s Fact Sheet: Doc# 19-010208-005;
Legal teams named for N.Y. litigation, Iss. 9, Feb. 2001, p11E; N.Y. judge enters confidentiality order in state litigation, Iss. 9, Feb. 2001, p12F
Pendleton, Mary et al. v. Parke-Davis, et al., No. 00-2736, E.D. La., Judge rules plaintiffs set damage amount artificially low, Iss. 8, Jan. 2001, p4B; Federal judge rejects remand reconsideration, Iss. 10, March 2001, p6C
Pinsker, Sanford et al. v. Warner-Lambert Co., et al., No. 00-2046, E.D. Pa., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p9*
In Re: Rezulin Litigation, No. 4122, Calif. Super., Los Angeles Co., Judge sets date for Rezulin trials in California, Iss. 10, March 2001, p7D*
Plaintiff’s Fact Sheet: Doc# 19-010308-005
In Re: Rezulin Litigation, No. 246, N.J. Super., Middlesex Co., Law Div., Special master orders master pleadings in New Jersey, Iss. 7, Dec. 2000, p10H; Liaison counsel files master complaint in New Jersey, Iss. 8, Jan. 2001, p4A; New Jersey judge outlines procedures for Rezulin litigation, Iss. 8, Jan. 2001, p6C; New Jersey adopts plaintiff’s fact sheet, Iss. 10, March 2001, p8F; Company denies knowing danger, removing examiner, Iss. 12, May 2001, p3A,B
In Re: Rezulin Products Liability Litigation, MDL Docket No. 1348, JPMDL, Warner-Lambert wants quick resolution, says MDL would create mass tort, Iss. 1, June 2000, p3A; Warner-Lambert names Kaye Scholer national consolidating counsel, Iss. 2, July 2000, p13; Plaintiffs’ committees seek discovery material, Iss. 2, July 2000, p13; 90 federal lawsuits transferred to MDL, Iss. 2, July 2000, p13
In Re: Rezulin Products Liability Litigation. MDL Docket No. 1348, S.D. N.Y., Rezulin PSC leadership elected in heated meeting, Iss. 2, July 2000, p8; Another attorney makes a move for MDL leadership, Iss. 3, Aug. 2000, p10A,B,C,L,M,N,O; Initial conference set in Rezulin MDL, Iss. 4, Sept. 4, p11; Judge names leaders is MDL who will hear Rezulin discovery matters, Iss. 5, Oct. 2000, p4A,G; Judge denies role to insurance company in Rezulin MDL, Iss. 5, Oct. 2000, p6B; Warner-Lambert proposes panel of medical experts; Rezulin plaintiffs object, Iss. 6, Nov. 2000, p4F,G; Plaintiffs and defense argue over timing, substance of discovery, Iss. 6, Nov. 2000, p4D,E; Warner-Lambert files opposition to remand motion, Iss. 7, Dec. 2000, p4E; Warner-Lambert opposes order to identify patients, Iss. 7, Dec. 2000, p5F; Judge Kaplan issues confidentiality order in Rezulin MDL, Iss. 7, Dec. 2000, p6C; Judge sets schedule for MDL discovery, Iss. 7, Dec. 2000, p6B; Stock ownership prompts a recusal, Iss. 7, Dec. 2000, p8; Judge sets conference for discussion of class action concerns, Iss. 8, Jan. 2001, p3E*
Amended Complain: Doc# 19-010111-104
Plaintiffs’ Committee’s Motion
Doc# 19-010111-106;
Plaintiffs argue Rezulin causes lasting injuries, Iss. 9, Feb. 2001, p4B; Company denies it sought removal of FDA official, Iss. 9, Feb. 2001, p6A; MDL judge schedules class action discovery, Iss. 9, Feb. 2001, p7D; Joinder of pharmacists, sales representatives ruled fraudulent in MDL, Iss. 10, March 2001, p3A; MDL judge sets conduct and use of depositions, Iss. 10, March 2001, p4E; MDL judge grants coordinated class, Iss. 10, March 2001, p6; National discovery foes into full swing, Iss. 11, April 2001, p7D; Benefit providers class actions are consolidated, Iss. 11, April 2001, p8F; Judge sets procedure for tracking motions, Iss. 11, April 2001, p11E; Plaintiffs seek information about electronic data, Iss. 12, May 2001, p4C; Deposition will probe international affairs, Iss. 12, April 2001, p4F; Failure to file is deemed admission of fraudulent joinder, Iss. 12, May 2001, p5D; Judge allows small extensions, Iss. 12, May 2001, p6E
Richardson, Brenda J. v. Warner-Lambert Co., et al., No. 00-09841-A, Texas Ct. at Law, Dallas Co., Houston firm files 2 wrongful death suits in state courts, Iss. 5, Sept. 2000, p12J
Rivers, Elizabeth et al. v. Wyeth-Ayerst Laboratories, et al., No. G-00-345, S.D. Texas, Galveston Div., Duract class is certified only for recovery of costs, Iss. 7, Dec. 2000, p15*
Class Certification Order: Doc# 28-001207-106
Class Dismissal Denial Order: Doc# 28-001207-107
Rose, Theodore et al. v. Parke-Davis et al., No. MICV 2000-2585, Mass. Super., Middlesex Co., Massachusetts couple claims fraud on FDA in Rezulin lawsuit, Iss. 2, July 2000, p4G
Rowan v. Warner-Lambert, No. MID-L-2623-00, N.J. Super., Middlesex Co., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p9*
Scherer, Charles et al. v. Parke-Davis, et al., Mass. Super., Middlesex Co., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-013
Seay, Rosetta et al. v. Warner-Lambert Co., et al., No. 00-2160, D.C. Super., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-107
Shaw, Andrea et al. v. Warner-Lambert Co., et al., Md. Cir., Montgomery Co., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-103
Teague, Robert et al. v. Parke-Davis, et al., No. 2000-101, Miss. Cir., Holmes Co., Attempts to join locals meet with mixed results in Mississippi lawsuits, Iss. 5, Oct. 2000, p13F,H
Thomas, Nancy G. et al. v. Warner-Lambert Corp., et al., No. YC 036093, Calif. Super., Los Angeles Co., California state judge stays state cases pending consolidation, Iss. 1, July 2000, p6F*
Complaint: Doc# 19-000727-008
Coordination Petition: Doc# 19-000727-009;
Lawyers wrangle over proper venue for Calif. consolidation, Iss. 3, Aug. 2000, p7E
Tucker, Stephen I. V. Warner-Lambert, et al., Phil. Com. Pls., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-005
Velerius, Wanda v. Warner-Lambert, No. C-1-00371, S.D. Ohio., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p8*
Complaint: Doc# 28-000406-007
Weisman, Alan v. Warner-Lambert Co., et al., No. 00-321, S.D. Ohio, Western Dist., Class actions, wrongful death complaints follow withdrawal of Rezulin, Iss. 1, June 2000, p9*